Cantourage Group SE (ETR:HIGH)

Market Cap	72.82M +42.8%
Revenue (ttm)	3.91M +78.0%
Net Income	126.46K +59.5%
EPS	n/a
Shares Out	12.47M
PE Ratio	575.88
Forward PE	60.41
Dividend	n/a
Ex-Dividend Date	n/a

Volume	4,091
Open	5.90
Previous Close	6.00
Day's Range	5.78 - 5.90
52-Week Range	2.32 - 6.86
Beta	-0.08
Analysts	Strong Buy
Price Target	10.50 (+79.8%)
Earnings Date	Aug 13, 2026

About Cantourage Group SE

Cantourage Group SE operates as a medical cannabis company in Europe and internationally. The company offers cannabis flowers, extracts, dronabinol, tetrahydrocannabinol, and cannabidiol products. It exports its products. The company distributes its products through pharmacies, wholesalers, and partners. Cantourage Group SE was founded in 2019 and is headquartered in Berlin, Germany.

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 2019
• Employees: 11
• Stock Exchange: Deutsche Börse Xetra
• Ticker Symbol: HIGH

Financial Performance

In 2025, Cantourage Group SE's revenue was 3.91 million, an increase of 77.97% compared to the previous year's 2.20 million. Earnings were 126,458, an increase of 59.48%.

Analyst Summary

According to 3 analysts, the average rating for HIGH stock is "Strong Buy." The 12-month stock price target is €10.50, which is an increase of 79.80% from the latest price.

Price Target

€10.50

(79.80% upside)

Analyst Consensus: Strong Buy

Data Source: S&P Global Market Intelligence

Fundamental and historical data is provided by S&P Global Market Intelligence.

Last checked:

Aug 27, 2026

Data Sources Report a data error